Trends of prescribing antimicrobial drugs for urinary tract infections in primary care in the Netherlands: a population-based cohort study

Objective Urinary tract infections (UTIs) are an important reason to consult a general practitioner (GP). Here, we describe antimicrobial drug prescribing patterns for UTIs by GPs in relation to the Dutch primary care guidelines. Methods We conducted a population-based cohort study in the Dutch Integrated Primary Care Information (IPCI)database, which encompasses approximately 2.5 million patients. All patients aged ≥12 years with at least 1 year of follow-up from 1996 to 2014 were extracted from the database. The number of prescriptions and choice of drug type were investigated over time and in different age categories. The choice of antimicrobial drug classes for UTIs and the duration of nitrofurantoin use in women were compared with the Dutch primary care guidelines of 1989, 1999, 2005 and 2013. Results The source population comprised 1 755 085 patients who received 2 019 335 antimicrobial drug prescriptions; 401 655 (35.1%) prescriptions were for UTIs (45.2% in women and 12.6% in men). The proportion of prescriptions for UTIs within all prescriptions with an indication code increased from 5.2% in 1996 to 14% in 2014 in men and from 28% in 1996 to 50% in 2014 in women. In men, UTIs were most frequently treated with fluoroquinolones during the entire study period, whereas fluoroquinolones were only advised as first choice in the latest guideline of 2013. In women, UTIs were increasingly (p<0.05) treated with nitrofuran derivatives with a statistically significant difference after implementation of the guideline of 2005. Compliance to the advised duration of nitrofurantoin prescriptions in women has increased since the guideline of 2005. Conclusions Antimicrobial drug prescribing for UTIs seemed to have increased over time. Prescribing in line with the UTI guidelines increased with regard to choice and duration of antimicrobial drugs. We showed that databases like IPCI, in which prescription and indication are monitored, can be valuable antibiotic stewardship tools.

[1]  H. Sillo,et al.  Utilization Trends of Antiviral and Antifungal Agents for Human Systemic Use in Tanzania From 2010 to 2017 Using the World Health Organization Collaborating Centre for Drug Statistics Methodology , 2021, Frontiers in Tropical Diseases.

[2]  Ventola Cl,et al.  The antibiotic resistance crisis: part 2: management strategies and new agents. , 2015, P & T : a peer-reviewed journal for formulary management.

[3]  C. L. Ventola The antibiotic resistance crisis: part 1: causes and threats. , 2015, P & T : a peer-reviewed journal for formulary management.

[4]  Mattijs E Numans,et al.  Antibiotic use in Dutch primary care: relation between diagnosis, consultation and treatment. , 2014, The Journal of antimicrobial chemotherapy.

[5]  M. Numans,et al.  Cystitis: antibiotic prescribing, consultation, attitudes and opinions. , 2014, Family practice.

[6]  C. Hoebe,et al.  Trends in Antibiotic Prescribing in Adults in Dutch General Practice , 2012, PloS one.

[7]  Betsy Foxman,et al.  The epidemiology of urinary tract infection , 2010, Nature Reviews Urology.

[8]  S. Nyberg,et al.  Association between Antimicrobial Consumption and Resistance in Escherichia coli , 2008, Antimicrobial Agents and Chemotherapy.

[9]  L. van Dijk,et al.  Antibiotics for respiratory, ear and urinary tract disorders and consistency among GPs. , 2008, The Journal of antimicrobial chemotherapy.

[10]  S. Cosgrove The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Betsy Foxman,et al.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. , 2002, The American journal of medicine.

[12]  J H van Bemmel,et al.  Postmarketing Surveillance Based on Electronic Patient Records: The IPCI Project , 1999, Methods of Information in Medicine.

[13]  S. Natsch,et al.  Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in The Netherlands in 2015 : NethMap 2016 , 2016 .

[14]  C. L. Ventola,et al.  The antibiotic resistance crisis: part 2: management strategies and new agents. , 2015, P & T : a peer-reviewed journal for formulary management.

[15]  C. D. Heijer,et al.  Antibiotica bij ongecompliceerde urineweginfecties: geen toename van resistentie in de afgelopen 5 jaar. , 2011 .

[16]  B. Pinxteren,et al.  NHG-Standaard Urineweginfectie , 2009 .

[17]       ,et al.  NHG-Standaard Urineweginfecties , 2005 .